These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15677905)

  • 41. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
    Miehsler W; Reinisch W; Moser G; Gangl A; Vogelsang H
    Am J Gastroenterol; 2001 Mar; 96(3):782-7. PubMed ID: 11280551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
    Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
    Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse.
    Iborra M; Herreras J; Boscá-Watts MM; Cortés X; Trejo G; Cerrillo E; Hervás D; Mínguez M; Beltrán B; Nos P
    Dig Dis Sci; 2019 Jun; 64(6):1612-1621. PubMed ID: 30604371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Doppler sonography of the superior mesenteric artery in Crohn's disease.
    Giovagnorio F; Diacinti D; Vernia P
    AJR Am J Roentgenol; 1998 Jan; 170(1):123-6. PubMed ID: 9423614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease.
    Lamers CB; Griffioen G; van Hogezand RA; Veenendaal RA
    Scand J Gastroenterol Suppl; 1999; 230():111-5. PubMed ID: 10499471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of Crohn's disease activity by doppler ultrasound of superior mesenteric artery and mural arteries in thickened bowel wall: cross-sectional study.
    Sjekavica I; Barbarić-Babić V; Krznarić Z; Molnar M; Cuković-Cavka S; Stern-Padovan R
    Croat Med J; 2007 Dec; 48(6):822-30. PubMed ID: 18074417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center.
    Farkas K; Rutka M; Ferenci T; Nagy F; Bálint A; Bor R; Milassin Á; Fábián A; Szántó K; Végh Z; Kürti Z; Lakatos PL; Szepes Z; Molnár T
    Expert Opin Biol Ther; 2017 Nov; 17(11):1325-1332. PubMed ID: 28819991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Azathioprine is effective in corticosteroid-dependent Asian inflammatory bowel disease patients.
    Thia KT; Li M; Ling KL; Kong SC; Ooi CJ
    Inflamm Bowel Dis; 2011 Mar; 17(3):809-15. PubMed ID: 20645318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.
    Cosnes J; Bourrier A; Laharie D; Nahon S; Bouhnik Y; Carbonnel F; Allez M; Dupas JL; Reimund JM; Savoye G; Jouet P; Moreau J; Mary JY; Colombel JF;
    Gastroenterology; 2013 Oct; 145(4):758-65.e2; quiz e14-5. PubMed ID: 23644079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
    Grover Z; Burgess C; Muir R; Reilly C; Lewindon PJ
    J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doppler study of splanchnic hemodynamics in Hirschsprung's disease.
    Pratap A; Tiwari A; Shakya VC; Yadav RP; Agarwal B; Koirala S; Shekhar Agrawal C; Adhikary S; Kumar A; Agrawal A
    Eur Surg Res; 2007; 39(3):148-52. PubMed ID: 17337892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Doppler ultrasound measurement of intestinal blood flow in inflammatory bowel disease.
    Maconi G; Imbesi V; Bianchi Porro G
    Scand J Gastroenterol; 1996 Jun; 31(6):590-3. PubMed ID: 8789898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
    Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
    Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators--a population-based study.
    Jakobsen C; Munkholm P; Paerregaard A; Wewer V
    Inflamm Bowel Dis; 2011 Aug; 17(8):1731-40. PubMed ID: 21744428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relapse rate following azathioprine withdrawal in maintaining remission for Crohn's disease: a meta-analysis.
    French H; Mark Dalzell A; Srinivasan R; El-Matary W
    Dig Dis Sci; 2011 Jul; 56(7):1929-36. PubMed ID: 21476031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease.
    Hassard PV; Vasiliauskas EA; Kam LY; Targan SR; Abreu MT
    Inflamm Bowel Dis; 2000 Feb; 6(1):16-20. PubMed ID: 10701145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.